Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 24, 2017

DrugPatentWatch Database Preview

Ciclopirox - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ciclopirox and what is the scope of freedom to operate?

is the generic ingredient in three branded drugs marketed by Cnty Line Pharms, Valeant Bermuda, Fougera Pharms, Perrigo New York, Cipla Ltd, Medimetriks Pharms, G And W Labs, Taro Pharm Inds, Actavis Mid Atlantic, Medicis, G And W Labs Inc, Perrigo, Paddock Llc, Mylan Pharms Inc, Taro, Hi Tech Pharma, Apotex Inc, Glenmark Pharms, Akorn, Teva Pharms, Tolmar, and Glenmark Generics, and is included in thirty-one NDAs. There are five patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ciclopirox has eighty-two patent family members in thirty-four countries.

There are ten drug master file entries for ciclopirox. Twenty-one suppliers are listed for this compound.

Summary for Generic Name: ciclopirox

Drug Master File Entries: see list10
Suppliers / Packagers: see list21
Bulk Api Vendors: see list54
Clinical Trials: see list4
Patent Applications: see list4,829
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ciclopirox at DailyMed

Pharmacology for Ingredient: ciclopirox

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
SUSPENSION;TOPICAL077092-001Aug 10, 2005ABRXNoNo► Subscribe► Subscribe
SHAMPOO;TOPICAL090269-001Feb 23, 2011ATRXNoNo► Subscribe► Subscribe
Taro Pharm Inds
SOLUTION;TOPICAL078144-001Sep 18, 2007ATRXNoNo► Subscribe► Subscribe
Fougera Pharms
GEL;TOPICAL077896-001Jun 10, 2008ABRXNoNo► Subscribe► Subscribe
SHAMPOO;TOPICAL021159-001Feb 28, 2003ATRXYesYes7,981,909► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus